Latin American Cardiovascular Drugs Markets

 


This research service covers the Latin America Cardiovascular drugs market from 2004 to 2011, with 2006 as the base year. Major markets were studied: Brazil and the Andean Region (which includes Colombia and Venezuela, countries that are estimated to achieve double digit growth rates in the forecast period).

Regular Price: USD 6,950

Special Price USD 4,865

30% OFF

* Required Fields

Regular Price: USD 6,950

Special Price USD 4,865

PAY BY INVOICE

Be the first to review this product

Table of Contents

Latin American Cardiovascular Drugs Markets, Market OverviewIntroductionExecutive SummaryResearch Scope and MethodologyMarket SegmentationGlossary of TermsOverviewOverview of the Latin American Cardiovascular Drugs MarketsMarket Engineering MeasurementsRegulatory FrameworkLatin American Cardiovascular Drugs Markets, Cardiovascular Drugs Markets in BrazilMarket MeasurementsMarket Profile and MeasurementsIndustry ChallengesMarket DriversMarket RestraintsAntihypertensive DrugsProduct MeasurementsProduct Pricing AnalysisCompetitive AnalysisAntidyslipidemic DrugsProduct MeasurementsProduct Pricing AnalysisCompetitive AnalysisOther Drugs (Antithrombotics and Antiarrhythmics) Product MeasurementsProduct Pricing AnalysisCompetitive AnalysisProduct Distribution Analysis Product Distribution StructureDrug PipelinesCardiovascular PipelinesLatin American Cardiovascular Drugs Markets, Cardiovascular Drugs Markets in the Andean Region (Colombia and Venezuela)Market MeasurementsMarket Profile and MeasurementsIndustry ChallengesMarket DriversMarket RestraintsAntihypertensive DrugsProduct MeasurementsProduct Pricing AnalysisCompetitive AnalysisAntidyslipidemic DrugsProduct MeasurementsProduct Pricing AnalysisCompetitive AnalysisOther Drugs (Antithrombotics and Antiarrhythmics)Product MeasurementsProduct Pricing AnalysisCompetitive AnalysisProduct Distribution AnalysisProduct Distribution StructureDrug PipelinesCardiovascular PipelinesLatin American Cardiovascular Drugs Markets, Decision Support DatabaseDecision Support DatabaseTotal Healthcare ExpenditureGovernment Healthcare ExpenditurePrivate Healthcare ExpenditurePer Capita Healthcare ExpenditurePharmaceutical R&D ExpenditurePrevalence of Hypertension




Related Research

Release Date : 03-Feb-17

Region : Latin America

Release Date : 11-Mar-16

Region : Latin America

Release Date : 28-Dec-2015

Region : Latin America

Release Date : 12-Jul-2013

Region : Latin America

Release Date : 28-Mar-13

Region : Latin America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.